{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:35:58Z","timestamp":1790998558314,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174032"],"award-info":[{"award-number":["82174032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374344"],"award-info":[{"award-number":["82374344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.phymed.2025.157140","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T03:33:32Z","timestamp":1754451212000},"page":"157140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Geniposidic acid alleviated metabolic dysfunction-associated steatotic liver disease by exciting SIRT6 signaling"],"prefix":"10.1016","volume":"146","author":[{"given":"Yingya","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmeng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.157140_bib0001","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2025.157140_bib0002","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2024.12.045","article-title":"Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD","volume":"82","author":"Barb","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.157140_bib0003","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s40265-017-0818-x","article-title":"Pemafibrate: first Global approval","volume":"77","author":"Blair","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.phymed.2025.157140_bib0004","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"Bo","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2025.157140_bib0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbagrm.2016.03.002","article-title":"Nuclear receptors and nonalcoholic fatty liver disease","volume":"1859","author":"Cave","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2025.157140_bib0006","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/physrev.00030.2018","article-title":"SIRT6, a mammalian deacylase with multitasking abilities","volume":"100","author":"Chang","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phymed.2025.157140_bib0007","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jep.2015.12.033","article-title":"Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2","volume":"179","author":"Chen","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2025.157140_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238568","article-title":"Geniposidic acid from Eucommia ulmoides Oliver Staminate flower tea mitigates cellular oxidative stress via activating AKT\/NRF2 signaling","volume":"27","author":"Cheng","year":"2022","journal-title":"Molecules."},{"key":"10.1016\/j.phymed.2025.157140_bib0009","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2025.157140_bib0010","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.molcel.2012.09.030","article-title":"The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis","volume":"48","author":"Dominy","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2025.157140_bib0011","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2025.157140_bib0012","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.celrep.2013.08.006","article-title":"Multiple regulatory layers of SREBP1\/2 by SIRT6","volume":"4","author":"Elhanati","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2025.157140_bib0013","article-title":"Geniposidic acid targeting FXR \u201cS332 and H447\u201d mediated conformational change to upregulate CYPs and miR-19a-3p to ameliorate drug-induced liver injury","volume":"12","author":"Fan","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.phymed.2025.157140_bib0014","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1021\/acs.jmedchem.1c02002","article-title":"Design, synthesis, and biological evaluation of triazolone derivatives as potent ppar\u03b1\/\u03b4 dual agonists for the treatment of nonalcoholic steatohepatitis","volume":"65","author":"Feng","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phymed.2025.157140_bib0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.157140_bib0016","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/13880209.2014.916310","article-title":"Anti-atherosclerotic effect of geniposidic acid in a rabbit model and related cellular mechanisms","volume":"53","author":"Gao","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.phymed.2025.157140_bib0017","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCRESAHA.120.318353","article-title":"SIRT6 Protects smooth muscle cells from senescence and reduces atherosclerosis","volume":"128","author":"Grootaert","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.phymed.2025.157140_bib0018","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.14336\/AD.2022.0413","article-title":"SIRT6 in aging, metabolism, inflammation and cardiovascular diseases","volume":"13","author":"Guo","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.phymed.2025.157140_bib0019","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: biological insights and disease relevance","volume":"5","author":"Haigis","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.phymed.2025.157140_bib0020","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2337\/dc19-1892","article-title":"Effects of novel dual GIP and GLP-1 receptor agonist tirzepatide on biomarkers of nonalcoholic steatohepatitis in patients with type 2 diabetes","volume":"43","author":"Hartman","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phymed.2025.157140_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177003","article-title":"Asperuloside activates hepatic NRF2 signaling to stimulate mitochondrial metabolism and restore lipid homeostasis in high fat diet-induced MAFLD","volume":"983","author":"He","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157140_bib0022","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.molcel.2022.09.018","article-title":"Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation","volume":"82","author":"Hou","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2025.157140_bib0023","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.157140_bib0024","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1002\/ptr.7819","article-title":"Geniposidic acid attenuates DSS-induced colitis through inhibiting inflammation and regulating gut microbiota","volume":"37","author":"Jiang","year":"2023","journal-title":"PhytOther Res."},{"key":"10.1016\/j.phymed.2025.157140_bib0025","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.molcel.2019.07.023","article-title":"Non-canonical mTORC2 signaling regulates brown adipocyte lipid catabolism through SIRT6-FoxO1","volume":"75","author":"Jung","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2025.157140_bib0026","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1096\/fj.201700098RR","article-title":"Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor","volume":"31","author":"Ka","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.phymed.2025.157140_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156004","article-title":"Metabolic dysfunction-associated steatotic liver disease and its link to cancer","volume":"160","author":"Kalligeros","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.phymed.2025.157140_bib0028","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamainternmed.2024.4661","article-title":"GLP-1 receptor agonists and risk for cirrhosis and related complications in patients with metabolic dysfunction-associated steatotic liver disease","volume":"184","author":"Kanwal","year":"2024","journal-title":"JAMa Intern. Med."},{"key":"10.1016\/j.phymed.2025.157140_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109190","article-title":"SIRT6 transcriptionally regulates fatty acid transport by suppressing ppar\u03b3","volume":"35","author":"Khan","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2025.157140_bib0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2010.06.009","article-title":"Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis","volume":"12","author":"Kim","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2025.157140_bib0031","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jep.2012.12.042","article-title":"Geniposidic acid protects against d-galactosamine and lipopolysaccharide-induced hepatic failure in mice","volume":"146","author":"Kim","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2025.157140_bib0032","doi-asserted-by":"crossref","first-page":"39","DOI":"10.20463\/pan.2022.0006","article-title":"Pharmacological systemic analysis of gardenia fructus against non-alcoholic fatty liver disease and validation of animal models","volume":"26","author":"Lee","year":"2022","journal-title":"Phys. Act. Nutr."},{"key":"10.1016\/j.phymed.2025.157140_bib0033","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-023-05061-7","article-title":"Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction","volume":"81","author":"LeFort","year":"2024","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phymed.2025.157140_bib0034","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41419-018-0984-0","article-title":"p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesis","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2025.157140_bib0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.kint.2023.09.028","article-title":"The transcription factor GATA6 accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting the role of anti-aging factor SIRT6 and impeding DNA damage repair","volume":"105","author":"Li","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2025.157140_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MEG.0000000000002471","article-title":"Side effect profile of pharmacologic therapies for liver fibrosis in nonalcoholic fatty liver disease: a systematic review and network meta-analysis","volume":"35","author":"Li","year":"2023","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.157140_bib0037","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/med.21753","article-title":"Emerging roles of SIRT6 in human diseases and its modulators","volume":"41","author":"Liu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phymed.2025.157140_bib0038","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41522-023-00399-z","article-title":"Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism","volume":"9","author":"Liu","year":"2023","journal-title":"NPJ. Biofilms. Microbiomes."},{"key":"10.1016\/j.phymed.2025.157140_bib0039","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41419-024-06537-5","article-title":"Hepatic Sirt6 activation abrogates acute liver failure","volume":"15","author":"Luo","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phymed.2025.157140_bib0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cell.2014.06.050","article-title":"Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism","volume":"158","author":"Masri","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2025.157140_bib0041","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrendo.2012.140","article-title":"GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus","volume":"8","author":"Meier","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phymed.2025.157140_bib0042","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature06736","article-title":"SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin","volume":"452","author":"Michishita","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2025.157140_bib0043","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1016\/j.celrep.2019.11.067","article-title":"SIRT6 Promotes hepatic beta-oxidation via activation of PPAR\u03b1","volume":"29","author":"Naiman","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2025.157140_bib0044","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jhep.2023.07.033","article-title":"Incretins (GLP-1 receptor agonists and dual\/triple agonists) and the liver","volume":"79","author":"Newsome","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.157140_bib0045","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2025.157140_bib0046","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3642463","article-title":"Protective effects of iridoid glycoside from Corni fructus on type 2 diabetes with nonalcoholic fatty liver in mice","author":"Niu","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phymed.2025.157140_bib0047","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.31205","article-title":"Cilofexor, a nonsteroidal FXR agonist, in patients with noncirrhotic NASH: a phase 2 randomized controlled trial","volume":"72","author":"Patel","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2025.157140_bib0048","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of ppar\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.157140_bib0049","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/liv.13270","article-title":"The therapeutic landscape of non-alcoholic steatohepatitis","volume":"37","author":"Perazzo","year":"2017","journal-title":"Liver. Int."},{"key":"10.1016\/j.phymed.2025.157140_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115640","article-title":"Metabolic dysfunction-associated steatotic liver disease: from pathogenesis to current therapeutic options","volume":"25","author":"Portincasa","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.157140_bib0051","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1111\/jcmm.15139","article-title":"Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2\/AMPK\/mTOR signalling pathways","volume":"24","author":"Shen","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phymed.2025.157140_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102404","article-title":"Inhibition of NLRP3-mediated crosstalk between hepatocytes and liver macrophages by geniposidic acid alleviates cholestatic liver inflammatory injury","volume":"55","author":"Song","year":"2022","journal-title":"Redox. Biol."},{"key":"10.1016\/j.phymed.2025.157140_bib0053","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.phymed.2025.157140_bib0054","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18228","article-title":"Geniposidic acid alleviates osteoarthritis progression through inhibiting inflammation and chondrocytes ferroptosis","volume":"28","author":"Sun","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phymed.2025.157140_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123096","article-title":"Anti-inflammatory effects of geniposidic Acid on Porphyromonas gingivalis-induced periodontitis in mice","volume":"10","author":"Tamura","year":"2022","journal-title":"Biomedicines."},{"key":"10.1016\/j.phymed.2025.157140_bib0056","doi-asserted-by":"crossref","first-page":"25521","DOI":"10.1021\/acsomega.2c02629","article-title":"Exploring anti-nonalcoholic fatty liver disease mechanism of gardeniae fructus by network pharmacology, molecular docking, and experiment validation","volume":"7","author":"Tang","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.phymed.2025.157140_bib0057","doi-asserted-by":"crossref","first-page":"29252","DOI":"10.1074\/jbc.M113.481473","article-title":"FoxO3 transcription factor and Sirt6 deacetylase regulate low density lipoprotein (LDL)-cholesterol homeostasis via control of the proprotein convertase subtilisin\/kexin type 9 (Pcsk9) gene expression","volume":"288","author":"Tao","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2025.157140_bib0058","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tibs.2010.07.009","article-title":"Chromatin regulation and genome maintenance by mammalian SIRT6","volume":"36","author":"Tennen","year":"2011","journal-title":"Trends. Biochem. Sci."},{"key":"10.1016\/j.phymed.2025.157140_bib0059","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMc1006581","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"363","author":"Violi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2025.157140_bib0060","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ajcn\/87.6.1926","article-title":"Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study","volume":"87","author":"Volcik","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phymed.2025.157140_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123211","article-title":"Metabolic disorders, inter-organ crosstalk, and inflammation in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"359","author":"Wang","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2025.157140_bib0062","first-page":"10","article-title":"A new geniposidic acid derivative exerts antiaging effects through antioxidative stress and autophagy induction","author":"Wang","year":"2021","journal-title":"Antioxidants. (Basel)"},{"key":"10.1016\/j.phymed.2025.157140_bib0063","article-title":"Sweroside prevents non-alcoholic steatohepatitis by suppressing activation of the NLRP3 inflammasome","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.157140_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112556","article-title":"Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response","volume":"255","author":"Yang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2025.157140_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116952","article-title":"Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways","volume":"177","author":"Yong","year":"2024","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2025.157140_bib0066","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.phymed.2025.157140_bib0067","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4161\/cc.8.11.8620","article-title":"Histone H3-K56 acetylation is important for genomic stability in mammals","volume":"8","author":"Yuan","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.phymed.2025.157140_bib0068","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jhep.2024.08.024","article-title":"Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases","volume":"82","author":"Zhong","year":"2025","journal-title":"J. Hepatol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325007792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325007792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:04:07Z","timestamp":1772823847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325007792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":68,"alternative-id":["S0944711325007792"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157140","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geniposidic acid alleviated metabolic dysfunction-associated steatotic liver disease by exciting SIRT6 signaling","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157140"}}